Skip to content

Optimization of PCI strategy by D-SPECT in patients with acute myocardial infarction

Optimization of PCI strategy by D-SPECT in patients with acute myocardial infarction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059934
Enrollment
Unknown
Registered
2022-05-13
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

Acute myocardial infarction with multivessel disease:Imaging examination
Stable coronary heart disease: Imaging examination

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. All adult STEMI patients with multiple infarct-related artery disease who had received successful PCI (direct PCI, salvage PCI, or drug intervention PCI); 2. Adult patients with exertional angina and angiographic evidence of at least one coronary artery stenosis in 40-80% of lesions.

Exclusion criteria

Exclusion criteria: 1. Hemodynamic instability (cardiogenic shock); 2. Prior coronary artery bypass grafting (CABG) or PCI, coronary artery calcification or chronic complete occlusion, criminal disease failure of PCI, and referral to CABG; 3. Persistent wheezing with bronchospasm of lung disease or a history of significant reactive airway; 4. Severe liver insufficiency or renal impairment requiring hemodialysis treatment; 5. Second or third degree ATrioventricular block and pathological sinus syndrome without pacemaker implantation; 6.Dipyridamole containing drugs within 6.48 hours; 7. Tumor patients undergoing radiotherapy and chemotherapy; 8. Refused to participate in the study; 9. Participate in other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
fractional flow reserve;myocardial flow reserve;

Countries

China

Contacts

Public ContactBai Ming

The First Hospital of Lanzhou University

baiming@vip.163.com+86 13893220909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026